olicard retard capsule cu eliberare prelungita 40 mg
abbott laboratories gmbh - isosorbidi mononitras - capsule cu eliberare prelungita - 40 mg
olicard retard capsule cu eliberare prelungita 60 mg
abbott laboratories gmbh - isosorbidi mononitras - capsule cu eliberare prelungita - 60 mg
caldefix comprimate efervescente 1000 mg + 880 ui
recordati romania srl - calciu + cholecalciferolum - comprimate efervescente - 1000 mg + 880 ui
xarelto
bayer ag - rivaroxaban - arthroplasty, replacement; venous thromboembolism - agenți antitrombotici - xarelto, administrat concomitent cu acidul acetilsalicilic (aas) singur sau cu asa plus clopidogrel sau ticlopidina, este indicat pentru prevenirea evenimentelor aterotrombotice la pacienții adulți după un sindrom coronarian acut (sca) cu valori crescute biomarkerii cardiaci. xarelto, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. prevenirea tromboembolismului venos (vte) la pacienții adulți supuși unei intervenții chirurgicale de înlocuire a șoldului sau a genunchiului. tratamentul trombozei venoase profunde (tvp) și embolie pulmonară (ep), și prevenirea tvp și ep recurente la adulți. adultsprevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
orfiril long 1000 mg
desitin arzneimittel gmbh - germania - acid valproicum + saruri - minicompr. elib. prel. - 1000mg - antiepileptice derivati de acizi grasi
orfiril long 150 mg
desitin arzneimittel gmbh - germania - acid valproicum + saruri - caps. cu elib. prel. - 150mg - antiepileptice derivati de acizi grasi
orfiril long 300 mg
desitin arzneimittel gmbh - germania - acid valproicum + saruri - caps. cu elib. prel. - 300mg - antiepileptice derivati de acizi grasi
orfiril long 500 mg
desitin arzneimittel gmbh - germania - acid valproicum + saruri - minicompr. elib. prel. - 500mg - antiepileptice derivati de acizi grasi
depakine 57,64 mg/ml
unither liquid manufacturing - franta - acid valproicum + saruri - sirop - 57,64mg/ml - antiepileptice derivati de acizi grasi
depakine chrono 500 mg
sanofi winthrop industrie - franta - acid valproicum + saruri - compr. cu elib. prel. - 500mg - antiepileptice derivati de acizi grasi